Navigation Links
4th ESU master class on medical treatment for urological cancer held in Barcelona, Spain
Date:6/18/2009

Arnhem, June 2009 The 4th ESU Master class on medical treatment for urological cancer is organised by the European School of Urology (ESU) on 27-28 June 2009 at the Barcel Hotel Sants in Barcelona, Spain. The format consists of three modules. Module 1 is entitled 'Hormonal and intravesical treatment and chemoprevention', module 2 'Immunotherapy and targeted therapies' and module 3 'Systemic cytotoxic chemotherapy and palliation'.

Each module comprises short state-of-the-art lectures followed by debates, case reports and interactive discussions. supplemented with case discussions and presentations. For the first time an online pre-assessment is included in the programme.

Professor Hein van Poppel, ESU course director: "The pre-assessment is meant to determine the level of a participant's knowledge before the start of the Masterclass. It is held online and consists of 20 multiple choice questions. The faculty will review the results and adjust the content of their lectures accordingly".

A post-assessment takes place after the last lecture and consists of 100 multiple choice questions to test the participant's knowledge on the topics taught during the ESU Masterclass.

This teaching programme has been developed by close collaboration between the European Association of Urology (EAU), the European School of Urology (ESU) and the European Board of Urology (EBU). "With rapid advances in cancer research, the oncologically oriented urologist requires insights on the clinical applicability and impact of the latest range of surgical and medical treatment strategies. The Masterclass is a prime venue to scrutinise current practices and survey the latest therapies that are still being tried or tested in various medical disciplines involved in cancer therapy", says Professor Ziya Kirkali, ESU course director. The ESU aims to provide a comprehensive update for urologists, but the Masterclass is open to other specialists, such as medical
'/>"/>

Contact: Lindy Brouwer
l.brouwer@uroweb.org
European Association of Urology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
2. RNs at Nine Catholic Healthcare West Hospitals Reach Agreement on New Master Pact
3. Charles A. Peck, M.D., F.A.C.P. Joins LifeMasters as New Medical Director Focused on Client Experience
4. Mastering Challenges & Measuring Successes for Quality Initiatives in Sales, Marketing and Product Development
5. Nursing Scholarships Offered by Western Governors University for Masters Degree Programs
6. Bioniche Amends Terms of Convertible Debt with Laurus Master Funds
7. LifeMasters Receives Full URAC Disease Management Accreditation
8. McMaster test detects the most prevalent respiratory viruses
9. The Centers for Medicare & Medicaid Services Extends LifeMasters Demonstration Project in Florida
10. Special Masters Appointed in Program to Resolve U.S. VIOXX(R) Product Liability Lawsuits
11. LifeMasters Strengthens Capital Structure with $15 Million in Funding from Existing Investors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... (PRWEB) September 23, 2014 "The primary purpose ... control," said an inventor from Sacramento, Ca.. "Call lights are ... or left hanging on the IV pole out of the ... the nurse call device whenever they need it, I created ... effectively position the nurse call device within easy reach. The ...
(Date:9/23/2014)... Davis, and Academia Sinica, the preeminent academic institution ... into a collaborative agreement to develop a unique ... research with opportunities to translate innovative technologies and ... agreement was signed Sept.12 in Taipei by Harris ... and President Chi-Huey Wong of Academia Sinica. The ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 AttorneyOne.com, a ... all the latest information from the FDA on ... 5, that its Private Label Jalapeno Bagels are recalled ... stones. Publix Jalapeno Bagels were sold in ... department. , Taking into consideration the latest developments, ...
(Date:9/23/2014)... Kathleen Doheny HealthDay Reporter ... at very low birth weights, breast milk is more likely ... infection known as cytomegalovirus (CMV), a new study finds. ... infants -- all of whom weighed 3.3 pounds or less ... of CMV infection, to see whether breast milk or transfusions ...
(Date:9/23/2014)... 2014 (HealthDay News) -- Both drinking and getting drunk ... alcohol abuse by high school students, a new study ... high school students who drink, could help expand alcohol-prevention ... drink, to stop them from becoming binge drinkers, the ... of first alcohol use and progression to first heavy ...
Breaking Medicine News(10 mins):Health News:Academia Sinica, UC Davis sign agreement on exchanges and tech transfer 2Health News:Publix Private Label Jalapeno Bagels Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 3Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 3
... Reactors Could Solve the Isotope Crisis within 24 months ... Nordion, a leading provider of medical isotopes and radiopharmaceuticals, ... Expert Review Panel on Medical Isotope and Technetium-99m (Tc-99m) ... to the shortage of medical radioisotopes is the completion ...
... male and seven female) with hepatic angiomyolipoma, with a ... Of these patients, dynamic contrast CT showed hepatic angiomyolipoma ... of a capsule, and prominent central vessels in six ... without a fat component in four cases with tuberous ...
... , DENVER July 30 Air Methods Corporation ... quarter ended June 30, 2009 after the close of the market on ... for Thursday, August 6, 2009 at 4:15 p.m. Eastern to discuss these ... the call by dialing (877) 883-0656 (domestic) or (706) 643-8826 (international) or ...
... , PLEASANTON, Calif., July 30 TriReme ... second product, a novel coronary dilatation catheter, designed to improve ... near side branches. The product will be marketed under the ... a first-in-class balloon dilatation catheter with a torquable shaft and ...
... centers didn,t increase weight, study found , THURSDAY, July 30 ... else,s home, they,re more likely to be heavier than average ... researchers report in the August issue of Pediatrics ... for in someone else,s home, rather than in their own ...
... WILMINGTON, Del., July 30 AstraZeneca (NYSE: ... a New Drug Application to the U.S. Food and Drug ... European Medicines Agency (EMEA) for an investigational drug, vandetanib 100 ... of advanced non-small cell lung cancer in patients previously treated ...
Cached Medicine News:Health News:MDS Nordion Submits Expression of Interest Proposal to Government of Canada on Medical Isotope and Generator Production 2Health News:MDS Nordion Submits Expression of Interest Proposal to Government of Canada on Medical Isotope and Generator Production 3Health News:TriReme Medical, Inc. Receives CE Marking for Glider(TM) PTCA Dilatation Catheter 2Health News:Infants Cared for in Another Home Become Heavier Toddlers 2Health News:Infants Cared for in Another Home Become Heavier Toddlers 3Health News:AstraZeneca Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer 2Health News:AstraZeneca Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer 3Health News:AstraZeneca Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer 4
(Date:9/23/2014)... This test can detect HIV infection if used ... by activities that can transfer body fluids from one person ... shared needles. , An in-vitro diagnostic home-use test ... test works by looking for your body,s response to fighting ... enabling patients to learn their status in a single visit ...
(Date:9/23/2014)... Research and Markets has announced the addition ... report to their offering. Though biotechnology ... products to treat cancer, diabetes, HIV/AIDS and autoimmune disorders ... stages of clinical drug testing for new biopharmaceuticals, as ... to upscale while anticipating FDA or EMA approval. During ...
(Date:9/23/2014)... FRANCISCO , Sept. 23, 2014  SiteOne Therapeutics ... of equity financing. Led by Sears Capital Management and ... Joe Zakrzewski , the $1.5 million financing positions ... program for pain and to further develop its technology ... pain indications. In conjunction with the financing, ...
Breaking Medicine Technology:WholeHealth Products announces the release of the FDA Cleared "HIV 1&2" Rapid Diagnostic Test for Professional and Retail 2Biopharmaceutical and Vaccine Production Markets 2Biopharmaceutical and Vaccine Production Markets 3SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 2SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 3
... HeartSine Technologies, Inc. was honored with the ... 50 event in Stormont, Belfast. The award was presented to ... pioneering business in developing areas of Belfast, Ireland. ... the Long Gallery in Stormont on behalf of HeartSine, said, ...
... N.Y., Oct. 11 Dr. Joan Fallon, founder and CEO ... research and development company focused on the treatment of neurological ... Life Sciences Summit 2010, held September 22-23 in Hauppauge, New ... New York at Stony Brook, Brookhaven National Laboratories and Cold ...
Cached Medicine Technology:HeartSine Technologies Honored With Belfast Ambassador Award at Belfast Business Top 50 Event 2Curemark Moderates Autism Panel at Life Sciences Summit 2010 2Curemark Moderates Autism Panel at Life Sciences Summit 2010 3
... ALLEGRO Topolyzer and T-CAT have been optimized ... vision correction and to interact in perfect ... systems. All necessary treatment and patient parameters ... the ALLEGRETTO WAVE laser systems via diskette, ...
RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% is the first and only therapy for patients with keratoconjunctivitis sicca (Dry Eye Disease) whose tear production is presumed to be supressed d...
ZYMAR™ ophthalmic solution is an anti-infective prescription eye drop that your doctor may instruct you to use if you have an eye infection caused by bacteria. Bacterial conjunctivitis is the e...
... P.M.® lets you sleep on ... in the morning awake with ... ready to take on the ... comfort and protection, this preservative-free ...
Medicine Products: